181 related articles for article (PubMed ID: 11281397)
21. [Acute lymphoblastic leukemia with p190 type bcr/abl chimeric mRNA at relapse].
Choi I; Matsushima T; Fujii T; Shiratsuchi M; Abe Y; Nishimura J; Nawata H; Muta K
Rinsho Ketsueki; 2002 Sep; 43(9):836-40. PubMed ID: 12412288
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J
Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256
[TBL] [Abstract][Full Text] [Related]
23. [Autologous graft of hematopoietic stem cells. Current and perspective strategies].
Hervé P
Rev Prat; 1991 Oct; 41(21):2072-7. PubMed ID: 1686122
[TBL] [Abstract][Full Text] [Related]
24. Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects.
Gökbuget N; Hoelzer D
Ann Hematol; 2004 Apr; 83(4):201-5. PubMed ID: 14648023
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
26. Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Peters SO; Stockschläder M; Hegewisch-Becker S; Krüger W; Weh HJ; Hossfeld DK; Zander AR
Bone Marrow Transplant; 1995 May; 15(5):783-4. PubMed ID: 7670406
[TBL] [Abstract][Full Text] [Related]
27. [Minor bcr/abl positive acute lymphoblastic leukemia preceded by knee joint pain due to bone marrow necrosis].
Sato K; Mori M; Meguro A; Miyoshi T; Nagai T; Muroi K; Komatsu N; Ozawa K
Rinsho Ketsueki; 2004 Nov; 45(11):1203-7. PubMed ID: 15609688
[TBL] [Abstract][Full Text] [Related]
28. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S
Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574
[TBL] [Abstract][Full Text] [Related]
29. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.
Arcaini L; Orlandi E; Alessandrino EP; Iacona I; Brusamolino E; Bonfichi M; Bernasconi P; Calatroni S; Tenore A; Montanari F; Troletti D; Pascutto C; Regazzi M; Lazzarino M
Bone Marrow Transplant; 2004 Jul; 34(2):175-9. PubMed ID: 15170171
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation.
Gemmel C; Cremer FW; Weis M; Witzens M; Moldenhauer G; Koniczek KH; Imbach U; Ho AD; Moos M; Goldschmidt H
Ann Hematol; 2002 Feb; 81(2):119-23. PubMed ID: 11907796
[TBL] [Abstract][Full Text] [Related]
32. [The role of imatinib in the treatment of acute lymphoid leukemias].
Poros A; Lovas N
Orv Hetil; 2005 May; 146(18 Suppl 1):905-10. PubMed ID: 15921303
[TBL] [Abstract][Full Text] [Related]
33. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia.
Rubnitz JE
J Biol Regul Homeost Agents; 2000; 14(3):182-6. PubMed ID: 11037050
[TBL] [Abstract][Full Text] [Related]
34. Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
Fruehauf S; Topaly J; Buss EC; Schad M; Goerner M; Zeller WJ; Ho AD
Haematologica; 2002 Dec; 87(12):ECR38. PubMed ID: 12495909
[No Abstract] [Full Text] [Related]
35. bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
Abla O; Gassas A; Stevens R; Grant R; Abdelhaleem M
J Pediatr Hematol Oncol; 2006 Feb; 28(2):98-9. PubMed ID: 16462583
[TBL] [Abstract][Full Text] [Related]
36. Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
Uzunel M; Ringdén O
Bone Marrow Transplant; 2004 Jan; 33(1):47-52. PubMed ID: 14704656
[TBL] [Abstract][Full Text] [Related]
37. Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population.
Maury S; Belhadj K; Chami I; Kuentz M; Cordonnier C; Bories D
Bone Marrow Transplant; 2001 Oct; 28(7):717-20. PubMed ID: 11704798
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
[TBL] [Abstract][Full Text] [Related]
39. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH
J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064
[TBL] [Abstract][Full Text] [Related]
40. Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group.
Mizuta S; Ito Y; Kohno A; Kiyoi H; Miyamura K; Tanimoto M; Takamatsu J; Naoe T; Morishima Y; Ueda R; Saito H
Bone Marrow Transplant; 1999 Oct; 24(7):777-84. PubMed ID: 10516682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
